People with heart problems who took the weight loss drug Wegovy maintained an average weight loss of 10% of their body weight 4 years after starting the drug, according to newly released study results.
May 14, 2024 – People with heart problems who took the weight loss drug Wegovy maintained an average weight loss of 10% of their body weight 4 years after starting the drug.
The findings are important because questions have lingered about the impacts of taking the drug long-term. The active ingredient in Wegovy is called semaglutide, which is the same active ingredient as in the diabetes drug Ozempic. Both are made by the Danish drug company Novo Nordisk. ."We see that once the majority of the weight loss is accrued, you don't go back and start to increase in weight if you stay on the drug.”were presented at this week’s European Congress on Obesity conference in Venice, Italy, and also published in the journalThe people in the study lost on average 3 inches from their waist circumference after 4 years.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy users keep weight off for 4 years: How Wegovy helps the heartPatients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the cost of the effective but expensive drug.
Read more »
Meta’s Threads no longer bleeds users, reaches 150 million monthly usersCosmin, a tech journalist with a career spanning over a decade, brings a wealth of experience to PhoneArena. His expertise lies in brands like Samsung and Nokia, and he has a keen interest in innovative technologies. After a brief stint in PR, Cosmin returned to tech journalism in 2016, committed to delivering clear and objective news.
Read more »
LinkedIn launches games in bid to keep users engagedJob networking site LinkedIn jumped into the gaming sphere this week with three new logic and word puzzles.
Read more »
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study saysThe results shed light on the long-term effects of Wegovy, and could boost Novo Nordisk's case to insurers and governments to cover the costly drug.
Read more »
Here's What Happens to People Who Stay on Wegovy Long TermThe results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive.
Read more »
Decades-old law limits access to Wegovy for Medicaid beneficiariesNew medications like Wegovy are changing the way people lose weight and manage obesity, but many Medicaid beneficiaries can't get them.
Read more »